8-10765626-G-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_017884.6(PINX1):c.762C>A(p.Ser254Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000294 in 1,461,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S254C) has been classified as Likely benign.
Frequency
Consequence
NM_017884.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PINX1 | NM_017884.6 | c.762C>A | p.Ser254Arg | missense_variant | 7/7 | ENST00000314787.8 | NP_060354.4 | |
LOC102723313 | NR_146188.1 | n.341-2774G>T | intron_variant, non_coding_transcript_variant | |||||
PINX1 | NM_001284356.2 | c.*160C>A | 3_prime_UTR_variant | 6/6 | NP_001271285.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PINX1 | ENST00000314787.8 | c.762C>A | p.Ser254Arg | missense_variant | 7/7 | 1 | NM_017884.6 | ENSP00000318966 | P2 | |
ENST00000657150.1 | n.174-2774G>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000804 AC: 2AN: 248776Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134984
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461454Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 727034
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 21, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at